Human Normal Immunoglobulin shortage — EU supply status & alternatives

Human Normal Immunoglobulin

—

🇦🇺 AUST R 328606 · CSL Behring Australia Pty Ltd

In supply · Australia

Iqymune

In supply · 🇦🇺 Australia · short in🌐 EU🇧🇪 BE🌐 IS

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Brand names	Iqymune

Therapeutic category	Auto-created by Federal Agency for Medicines and Health Products — PharmaStatus scraper

Controlled substance	No

Marketing-authorisation holders	CSL Behring Australia Pty Ltd, Octapharma Australia Pty Ltd, Bio Products Laboratory Limited, Link Medical Products Pty Ltd T/A Link Pharmaceuticals

Registrations on file	19

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 15 resolved events

◷

0–1 months

Historical pattern from resolved shortage records — not a prediction of this event.

Shortage status by regulator official notices

🌐

EMA · 1d ago

High

🌐

IMA · 1d ago

Medium

🇧🇪

FAMHP · 1d ago

Medium

Verified timeline regulator events

🇧🇪 1 June 2026

medium reported

🇧🇪 23 Mar 2026

medium reported

🌐 22 Jan 2026

Shortage resolved

🌐 14 Jan 2026

Shortage resolved

🌐 12 Jan 2026

Shortage resolved

🌐 9 Jan 2026

Shortage resolved

Sources official regulators

🌐

EMA

verified 1d ago

verify ↗

🌐

IMA

verified 1d ago

verify ↗

🇧🇪

FAMHP

verified 1d ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders19 registrations · 4 MA holders

Product	Strength	Form	Market	MA holder	Status
HIZENTRA AU Human Normal Immunoglobulin 20% Solution for Subcutaneous	20%	—	🇦🇺 AU	CSL Behring Australia Pty Ltd	Active
Cutaquig	4g	—	🇦🇺 AU	Octapharma Australia Pty Ltd	Active
Cutaquig	8g	—	🇦🇺 AU	Octapharma Australia Pty Ltd	Active
Cutaquig	3.3g	—	🇦🇺 AU	Octapharma Australia Pty Ltd	Active
Cutaquig	2g	—	🇦🇺 AU	Octapharma Australia Pty Ltd	Active
Cutaquig	1g	—	🇦🇺 AU	Octapharma Australia Pty Ltd	Active
Cutaquig	1.65g	—	🇦🇺 AU	Octapharma Australia Pty Ltd	Active
Subgam, Human Normal Immunoglobulin	160G	injection	🇬🇧 GB	Bio Products Laboratory Limited	Active
HIZENTRA human normal immunoglobulin 20% solution for subcutaneous	20%	—	🇦🇺 AU	CSL Behring Australia Pty Ltd	Active
Intratect 5%	5%	—	🇦🇺 AU	Link Medical Products Pty Ltd T/A Link Pharmaceuticals	Active
Intratect	5g	—	🇦🇺 AU	Link Medical Products Pty Ltd T/A Link Pharmaceuticals	Active
Intratect	10g	—	🇦🇺 AU	Link Medical Products Pty Ltd T/A Link Pharmaceuticals	Active
Intratect	20g	—	🇦🇺 AU	Link Medical Products Pty Ltd T/A Link Pharmaceuticals	Active
Intratect	1g	—	🇦🇺 AU	Link Medical Products Pty Ltd T/A Link Pharmaceuticals	Active
PANZYGA human normal immunoglobulin	30g	—	🇦🇺 AU	Octapharma Australia Pty Ltd	Active

+4 more registrations on file

Mederti Drug Report

Generated 6 July 2026 · Australia market · 3 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.